Liquid Biopsy for Precision Oncology East Coast on July 20-22, 2026 in Boston, United States

Reconvene with the wider liquid biopsy community at the 5th Liquid Biopsy for Precision Oncology Summit East Coast, your laser-focused forum accelerating the real-world application and adoption of liquid biopsies.

Prepare for the most strategic meeting yet, with compelling data spanning early molecular response through to next-generation MRD monitoring, alongside critical discussions addressing barriers in scaling, from analytical validation and cross-modality integration, to building regulatory-ready evidence bases required for MRD to serve as a clinical endpoint.

Look forward to in-depth presentations and interactive discussions on patient selection, dose optimization, companion diagnostic development, ultra-sensitive assays and more. Let’s unite in shaping the future of precision medicine to detect earlier, monitor smarter and act faster, ultimately improving outcomes and saving patient lives.

URLs:

Website: https://go.evvnt.com/3519780-0?pid=10008

Tickets: https://go.evvnt.com/3519780-2?pid=10008

Brochure: https://go.evvnt.com/3519780-3?pid=10008

Prices:

Drug Developer, Academic and Not-for-Profit Pricing - 3 Day Pass (Conference + Engager): USD 0.50,

Drug Developer Pricing - 2 Day Pass (Conference Only): USD 0.50,

Service Provider Pricing - 2 Day Pass (Conference Only): USD 3899.00

Speakers: Raluca Budiu-Predoiu, Director, Precision Medicine, Abbvie, Kristiyana Kaneva, Senior Medical Director, Clinical Development and Oncology Early Development, Abbvie, Dishant Kalra, Head, Precision Medicine, Astellas Pharma, Diana Vega, Global Senior Director, Early Detection, AstraZeneca, Erica Schleifman, Senior Director, Cancer Biomarker Development, AstraZeneca, Duane Hassane, Senior Director and Head, Translational Omics, Hematology R and D, AstraZeneca, Lauren Leiman, Executive Director, BLOODPAC, Jon Baden, Executive Director and Head, Precision Medicine, Bristol Myers Squibb, Zheng Feng, Head, Clinical Genomics, Global Clinical Biomarkers and Companion Diagnostics, EMD Serono, Rajiv Raja, Executive Director, Oncology Translational Medicine, GSK, Melissa Reuter, Scientific Director, Global Diagnostic Lead, Johnson and Johnson, Viraj Tyagi, Alliance Leader, Precision Medicine and Diagnostics, Johnson and Johnson, Mike Kagey, Vice President, Translational Medicine, Leap Therapeutics, Zhen Su, Chief Executive Officer, Marengo Therapeutics, Aparna Parikh, Program Director, GI Oncology, Massachusetts General Hospital, Rebecca Leary, Lab Head and Director, Next-Generation Diagnostics, Novartis, William Pierceall, Executive Director, Early Oncology Translational Development, Pfizer, I-Ming Wang, Director, Translational Oncology Lead, Pfizer, Dimple Modi, Senior Director, Oncology Precision Medicine, Regeneron, Brian Baker, Executive Director, Regulatory Affairs, In Vitro Diagnostics, Regeneron, Feng Hong, Senior Director and Head, Clinical Laboratory Operations, Precision Medicine, Regeneron, Minakshi Guha, Associate Director, Precision and Translational Medicine, Takeda, Erik Koenig, Senior Director and Head, Precision Translational Medicine, Takeda

Category: Conferences | Science, Health and Medicine

Date and Time: 20th July 2026 at 3:00 pm to 22nd July 2026 at 5:10 pm